source
- AstraZeneca and Ionis report failure of eplontersen in ATTR-CM trialAstraZeneca and Ionis said their nucleic‑acid drug eplontersen did not meet the primary goal in a large study of patients with transthyretin‑mediated amyloid cardiomyopathy (ATTR‑CM). Over a 140‑we…
- HHS proposes new rule to compensate Covid-19 vaccine injury claimsThe U.S. Department of Health and Human Services has issued a proposed rule that would create a compensation mechanism for people who say they were injured by Covid-19 vaccines. The new system is…